drugset / Trial / NCT00135018

Study on the Neoadjuvant Use of Chemotherapy and Celecoxib Therapy in Patients With Invasive Breast Cancer

NCT00135018 ↗

Non-randomizedSingle-groupOpen-labelTreatment

Summary

This study will investigate whether cyclooxygenase inhibition with celecoxib will add any benefit to preoperative chemotherapy alone for breast cancer patients.

Timeline

Start
2006-02
Primary completion
2011-12
Completion
2012-05

Drugs

EvaluationDrugModalityDoseRoute
Subject Celecoxib Other / unclassified — —

Indications